凝血酶原蛋白-1 推动慢性肾脏病的心脏重塑

IF 8.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Sohel M. Julovi MBBS, PhD , Katie Trinh BSc(Adv), MBBS , Harry Robertson BMedSc(Hons-I) , Cuicui Xu BSc, PhD , Nikita Minhas PhD , Seethalakshmi Viswanathan MBBS , Ellis Patrick BSc(Hons), PhD , John D. Horowitz MBBS, PhD , Daniel N. Meijles PhD , Natasha M. Rogers MBBS(Hons), PhD
{"title":"凝血酶原蛋白-1 推动慢性肾脏病的心脏重塑","authors":"Sohel M. Julovi MBBS, PhD ,&nbsp;Katie Trinh BSc(Adv), MBBS ,&nbsp;Harry Robertson BMedSc(Hons-I) ,&nbsp;Cuicui Xu BSc, PhD ,&nbsp;Nikita Minhas PhD ,&nbsp;Seethalakshmi Viswanathan MBBS ,&nbsp;Ellis Patrick BSc(Hons), PhD ,&nbsp;John D. Horowitz MBBS, PhD ,&nbsp;Daniel N. Meijles PhD ,&nbsp;Natasha M. Rogers MBBS(Hons), PhD","doi":"10.1016/j.jacbts.2024.01.010","DOIUrl":null,"url":null,"abstract":"<div><p>Patients with chronic kidney disease (CKD) face a high risk of cardiovascular disease. Previous studies reported that endogenous thrombospondin 1 (TSP1) involves right ventricular remodeling and dysfunction. Here we show that a murine model of CKD increased myocardial TSP1 expression and produced left ventricular hypertrophy, fibrosis, and dysfunction. TSP1 knockout mice were protected from these features. In vitro, indoxyl sulfate is driving deleterious changes in cardiomyocyte through the TSP1. In patients with CKD, TSP1 and aryl hydrocarbon receptor were both differentially expressed in the myocardium. Our findings summon large clinical studies to confirm the translational role of TSP1 in patients with CKD.</p></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"9 5","pages":"Pages 607-627"},"PeriodicalIF":8.4000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452302X24000378/pdfft?md5=1bebe1fb29e4a8ad99df4bc1befd59eb&pid=1-s2.0-S2452302X24000378-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease\",\"authors\":\"Sohel M. Julovi MBBS, PhD ,&nbsp;Katie Trinh BSc(Adv), MBBS ,&nbsp;Harry Robertson BMedSc(Hons-I) ,&nbsp;Cuicui Xu BSc, PhD ,&nbsp;Nikita Minhas PhD ,&nbsp;Seethalakshmi Viswanathan MBBS ,&nbsp;Ellis Patrick BSc(Hons), PhD ,&nbsp;John D. Horowitz MBBS, PhD ,&nbsp;Daniel N. Meijles PhD ,&nbsp;Natasha M. Rogers MBBS(Hons), PhD\",\"doi\":\"10.1016/j.jacbts.2024.01.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Patients with chronic kidney disease (CKD) face a high risk of cardiovascular disease. Previous studies reported that endogenous thrombospondin 1 (TSP1) involves right ventricular remodeling and dysfunction. Here we show that a murine model of CKD increased myocardial TSP1 expression and produced left ventricular hypertrophy, fibrosis, and dysfunction. TSP1 knockout mice were protected from these features. In vitro, indoxyl sulfate is driving deleterious changes in cardiomyocyte through the TSP1. In patients with CKD, TSP1 and aryl hydrocarbon receptor were both differentially expressed in the myocardium. Our findings summon large clinical studies to confirm the translational role of TSP1 in patients with CKD.</p></div>\",\"PeriodicalId\":14831,\"journal\":{\"name\":\"JACC: Basic to Translational Science\",\"volume\":\"9 5\",\"pages\":\"Pages 607-627\"},\"PeriodicalIF\":8.4000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2452302X24000378/pdfft?md5=1bebe1fb29e4a8ad99df4bc1befd59eb&pid=1-s2.0-S2452302X24000378-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Basic to Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452302X24000378\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24000378","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

慢性肾脏病(CKD)患者罹患心血管疾病的风险很高。以前的研究报告称,内源性凝血酶原 1 (TSP1) 与右心室重塑和功能障碍有关。在这里,我们发现一种小鼠慢性肾脏病模型增加了心肌 TSP1 的表达,并导致左心室肥厚、纤维化和功能障碍。而 TSP1 基因敲除小鼠则不会出现这些特征。在体外,硫酸吲哚酯通过 TSP1 驱动心肌细胞发生有害变化。在慢性肾脏病患者中,TSP1 和芳基烃受体在心肌中均有不同程度的表达。我们的研究结果呼吁开展大型临床研究,以证实 TSP1 在慢性肾脏病患者中的转化作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease

Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease

Patients with chronic kidney disease (CKD) face a high risk of cardiovascular disease. Previous studies reported that endogenous thrombospondin 1 (TSP1) involves right ventricular remodeling and dysfunction. Here we show that a murine model of CKD increased myocardial TSP1 expression and produced left ventricular hypertrophy, fibrosis, and dysfunction. TSP1 knockout mice were protected from these features. In vitro, indoxyl sulfate is driving deleterious changes in cardiomyocyte through the TSP1. In patients with CKD, TSP1 and aryl hydrocarbon receptor were both differentially expressed in the myocardium. Our findings summon large clinical studies to confirm the translational role of TSP1 in patients with CKD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC: Basic to Translational Science
JACC: Basic to Translational Science CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
14.20
自引率
1.00%
发文量
161
审稿时长
16 weeks
期刊介绍: JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信